ECSP055729A - Nuevos inhibidores biciclicos de la lipasa sensible a hormonas - Google Patents

Nuevos inhibidores biciclicos de la lipasa sensible a hormonas

Info

Publication number
ECSP055729A
ECSP055729A EC2005005729A ECSP055729A ECSP055729A EC SP055729 A ECSP055729 A EC SP055729A EC 2005005729 A EC2005005729 A EC 2005005729A EC SP055729 A ECSP055729 A EC SP055729A EC SP055729 A ECSP055729 A EC SP055729A
Authority
EC
Ecuador
Prior art keywords
hormone
inhibitors
sensitive lipase
new bicycle
lipase
Prior art date
Application number
EC2005005729A
Other languages
English (en)
Inventor
Stefan Petry
Karl-Heinz Baringhaus
Norbert Tennagels
Guenter Mueller
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of ECSP055729A publication Critical patent/ECSP055729A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18—Benzotriazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen benzotriazoles de la fórmula general (I) en la que R1 a R8 tienen los significados mencionados anteriormente, así como procedimientos para su preparación. Los compuestos presentan un efecto inhibidor sobre la lipasa sensible a hormonas.
EC2005005729A 2002-10-12 2005-04-11 Nuevos inhibidores biciclicos de la lipasa sensible a hormonas ECSP055729A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10247680A DE10247680B4 (de) 2002-10-12 2002-10-12 Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase

Publications (1)

Publication Number Publication Date
ECSP055729A true ECSP055729A (es) 2005-07-06

Family

ID=32038583

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005005729A ECSP055729A (es) 2002-10-12 2005-04-11 Nuevos inhibidores biciclicos de la lipasa sensible a hormonas

Country Status (38)

Country Link
EP (1) EP1554259B1 (es)
JP (2) JP4658607B2 (es)
KR (1) KR20050059254A (es)
CN (1) CN100366616C (es)
AR (1) AR041565A1 (es)
AT (1) ATE349433T1 (es)
AU (1) AU2003275997B8 (es)
BR (1) BR0315257A (es)
CA (1) CA2501734C (es)
CR (1) CR7717A (es)
CY (1) CY1106358T1 (es)
DE (2) DE10247680B4 (es)
DK (1) DK1554259T3 (es)
EC (1) ECSP055729A (es)
ES (1) ES2277152T3 (es)
GT (1) GT200300214A (es)
HN (1) HN2003000316A (es)
HR (1) HRP20050325A2 (es)
IL (1) IL167907A (es)
JO (1) JO2497B1 (es)
MA (1) MA27404A1 (es)
MX (1) MXPA05003359A (es)
MY (1) MY138057A (es)
NO (1) NO20052291L (es)
OA (1) OA12941A (es)
PA (1) PA8585101A1 (es)
PE (1) PE20040776A1 (es)
PL (1) PL374605A1 (es)
PT (1) PT1554259E (es)
RS (1) RS51543B (es)
RU (1) RU2325385C2 (es)
SV (1) SV2004001633A (es)
TN (1) TNSN05105A1 (es)
TW (1) TWI313265B (es)
UA (1) UA79994C2 (es)
UY (1) UY28015A1 (es)
WO (1) WO2004035550A1 (es)
ZA (1) ZA200501757B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005002130A1 (de) 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026809A1 (de) * 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026808A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005048897A1 (de) * 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049954A1 (de) 2005-10-19 2007-05-31 Sanofi-Aventis Deutschland Gmbh Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049953A1 (de) * 2005-10-19 2007-04-26 Sanofi-Aventis Deutschland Gmbh Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
FR2915198B1 (fr) * 2007-04-18 2009-12-18 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
FR2915197B1 (fr) 2007-04-18 2009-06-12 Sanofi Aventis Sa Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
FR2915199B1 (fr) * 2007-04-18 2010-01-22 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
MX342128B (es) * 2008-12-24 2016-09-14 Bial - Portela & C A S A Compuestos farmaceuticos.
US8329904B2 (en) 2009-05-12 2012-12-11 Hoffmann-La Roche Inc. Azacyclic derivatives
US8440710B2 (en) 2009-10-15 2013-05-14 Hoffmann-La Roche Inc. HSL inhibitors useful in the treatment of diabetes
US8097634B2 (en) 2010-04-15 2012-01-17 Hoffmann-La Roche Inc. Azacyclic derivatives
US8450350B2 (en) * 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
US8722721B2 (en) * 2011-03-16 2014-05-13 Hoffmann-La Roche Inc. SEC-hydroxycyclohexyl derivatives
US8703807B2 (en) * 2011-03-17 2014-04-22 Hoffmann-La Roche Inc. Azaspirodecanone compounds
US8809384B2 (en) * 2011-03-25 2014-08-19 Hoffmann-La Roche Inc. Azaspirodecanone compounds
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
GB201321740D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
WO2015089137A1 (en) 2013-12-11 2015-06-18 Karos Pharmaceuticals, Inc. Acylguanidines as tryptophan hydroxylase inhibitors
WO2016109501A1 (en) 2014-12-30 2016-07-07 Karos Pharmaceuticals, Inc. Amide compounds as tryptophan hydroxylase inhibitors
US9611201B2 (en) 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
CA3119912A1 (en) 2018-11-14 2020-05-22 Altavant Sciences Gmbh A crystalline spirocyclic compound inhibitor of tryptophan hydroxylase 1 (tph1) for treating diseases or disorders associated with peripheral serotonin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1124716A (en) * 1978-10-20 1982-06-01 Michael J. Simons Blocked benzotriazole compounds as development restrainer precursors
US5369086A (en) * 1993-04-28 1994-11-29 Zeneca Limited N-benzotriazoles
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
WO2002090355A1 (en) * 2001-05-05 2002-11-14 Smithkline Beecham P.L.C. N-aroyl cyclic amines
EP1458374A2 (en) * 2001-12-14 2004-09-22 Novo Nordisk A/S Compounds and uses thereof for decreasing activity of hormone-sensitive lipase

Also Published As

Publication number Publication date
CA2501734A1 (en) 2004-04-29
DK1554259T3 (da) 2007-05-07
RU2325385C2 (ru) 2008-05-27
WO2004035550A1 (de) 2004-04-29
HK1080473A1 (en) 2006-04-28
MY138057A (en) 2009-04-30
BR0315257A (pt) 2005-08-23
TW200413335A (en) 2004-08-01
DE10247680A1 (de) 2004-04-22
HN2003000316A (es) 2006-06-12
AR041565A1 (es) 2005-05-18
EP1554259B1 (de) 2006-12-27
HRP20050325A2 (en) 2005-06-30
ATE349433T1 (de) 2007-01-15
AU2003275997B2 (en) 2010-03-25
ZA200501757B (en) 2005-09-07
SV2004001633A (es) 2004-03-19
AU2003275997B8 (en) 2010-09-30
JP4658607B2 (ja) 2011-03-23
JP2011026342A (ja) 2011-02-10
CN100366616C (zh) 2008-02-06
KR20050059254A (ko) 2005-06-17
AU2003275997A1 (en) 2004-05-04
CR7717A (es) 2007-09-14
NO20052291D0 (no) 2005-05-10
NO20052291L (no) 2005-05-10
UA79994C2 (en) 2007-08-10
PT1554259E (pt) 2007-02-28
CY1106358T1 (el) 2011-10-12
PL374605A1 (en) 2005-10-31
JP2006509734A (ja) 2006-03-23
JO2497B1 (en) 2009-10-05
OA12941A (en) 2006-10-13
UY28015A1 (es) 2004-04-30
IL167907A (en) 2010-12-30
GT200300214A (es) 2007-02-05
ES2277152T3 (es) 2007-07-01
MA27404A1 (fr) 2005-06-01
PE20040776A1 (es) 2004-12-24
RS20050207A (sr) 2007-08-03
CA2501734C (en) 2011-05-31
TNSN05105A1 (en) 2007-05-14
MXPA05003359A (es) 2005-06-22
TWI313265B (en) 2009-08-11
EP1554259A1 (de) 2005-07-20
PA8585101A1 (es) 2004-09-16
RS51543B (sr) 2011-06-30
RU2005114394A (ru) 2006-01-20
DE50306134D1 (de) 2007-02-08
DE10247680B4 (de) 2005-09-01
CN1688555A (zh) 2005-10-26

Similar Documents

Publication Publication Date Title
ECSP055729A (es) Nuevos inhibidores biciclicos de la lipasa sensible a hormonas
ECSP20027480A (es) Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa
TN2010000052A1 (fr) Derives de pyrazole et leur utilisation comme inhibiteurs de raf
UY27729A1 (es) Inhibidores de quinasas.
CR11819A (es) Compuestos de isoindolina 5-sustituidos
NI201000059A (es) Inhibidores de la cinasa c-fms.
MX341849B (es) Nitrilos espirociclicos como inhibidores de proteasa.
CU20070160A7 (es) Pirrolopirazoles, inhibidores potentes de quinasa
CR11518A (es) Compuestos de carbamoilo como inhibidores de dgat1 190
MX379532B (es) Inhibidores de cdk.
DOP2009000169A (es) Derivados ciclados como inhibidores de eg-5
ECSP11011411A (es) Derivados de prolina como inhibidores de catepsina
CR8744A (es) Compuestos terapeuticos
CO6290760A2 (es) Derivados de alcoholes de 1 fenil-2-piridinilalquilo como inbidores de la fosfodiesterasa
BRPI0418031A (pt) inibidores de quinase fosfonato-substituìdos
CR10277A (es) Pirazolquinolonas como potentes inhibidores de parp
HN1999000106A (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa.
DOP2009000106A (es) Compuestos de pirazol y triazol sustituídos como inhibidores de ksp
CO6361924A2 (es) Nuevas lactamas como inhibidores de beta secretasa
ECSP099738A (es) Derivados de pirazolona como inhibidores de pde4
CR9058A (es) Derivados de indol como inhibidores de la adenilato ciclasa soluble
PA8630801A1 (es) Nuevos imidazoles
ATE246174T1 (de) Tosylprolin-derivate als thymidylat-synthase inhibitoren
CU20130037A7 (es) Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CR9238A (es) Pirrolopirazoles, potentes inhibidores de cinasa